PMEL and neoplasm: Using a similar strategy, we molecularly cloned the TCR genes of A*02:01/SSX241-49, A*24:02/gp100-intron4, B*07:02/NY-ESO-160-72, B*07:02/MAGE-A1289-297, B*18:01/MAGE-A3167-176, B*40:01/gp100448-458, C*03:04/NY-ESO-192-100, C*05:01/tyrosinase460-468, C*06:02/gp100190-198, and C*07:01/gp100479-487 and confirmed their tumor reactivities (Table 1, Figure 5—figure supplements 2–7, Supplementary file 3).